HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,200 | +5.9% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $36,070 | -5.6% | 1,000 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $38,190 | -32.9% | 1,000 | 0.0% | 0.01% | -36.4% |
| Q4 2022 | $56,900 | -99.9% | 1,000 | 0.0% | 0.02% | +29.4% |
| Q3 2022 | $39,540,000 | -10.1% | 1,000 | 0.0% | 0.02% | -5.6% |
| Q2 2022 | $44,000,000 | +6.3% | 1,000 | 0.0% | 0.02% | +20.0% |
| Q1 2022 | $41,380,000 | +2.9% | 1,000 | 0.0% | 0.02% | +7.1% |
| Q4 2021 | $40,210,000 | -1.2% | 1,000 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $40,680,000 | -10.4% | 1,000 | 0.0% | 0.02% | -16.7% |
| Q2 2021 | $45,410,000 | +8.9% | 1,000 | 0.0% | 0.02% | +5.9% |
| Q1 2021 | $41,690,000 | -2.4% | 1,000 | 0.0% | 0.02% | -15.0% |
| Q4 2020 | $42,710,000 | +62.5% | 1,000 | 0.0% | 0.02% | +42.9% |
| Q3 2020 | $26,280,000 | -2.0% | 1,000 | 0.0% | 0.01% | -6.7% |
| Q2 2020 | $26,810,000 | +148844.4% | 1,000 | 0.0% | 0.02% | +25.0% |
| Q1 2020 | $18,000 | 0.0% | 1,000 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $18,000 | +12.5% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $16,000 | -5.9% | 1,000 | 0.0% | 0.01% | -9.1% |
| Q2 2019 | $17,000 | +6.2% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $16,000 | +6.7% | 1,000 | 0.0% | 0.01% | -15.4% |
| Q4 2018 | $15,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |